My take on the rns19 Oct 2020 10:28
What we have learned is that omega will be producing a minimum of 200k tests a week equating to 10 million per year and imo will be selling for a minimum of £4 per test. So we know omega have a minimum of £40million over the next year from the UK government as these tests will be needed regardless of vaccine development. Combine this what the food intolerance tests, antigen tests and mologic antibody tests and the very strong likelihood that the capacity will reach 1 million a week early next year omega are a very strong buy at the current market cap.